#United States #healthcare #Bitcoin #Santa Clara #Semler Scientific

Semler Scientific Reports Record Financial Results in 2024

Semler Scientific, Inc. (Nasdaq: SMLR), a leader in healthcare technology, recently published its financial results for the fourth quarter and the full year of 2024. The company has impressed stakeholders with an operational income of $20.9 million, which positions them favorably in the healthcare market despite a decline in overall revenues.

As of December 31, 2024, Semler holds an impressive 3,192 bitcoins, valued at around $300 million. This achievement comes from a deliberate strategy implemented by the company to expand its bitcoin treasury. CEO Doug Murphy-Chutorian expressed satisfaction with their operational income, stating, "We continually support innovation within our healthcare business, while also focusing our financial efforts on acquiring and retaining bitcoin."

Embracing a Bitcoin Treasury Strategy

The year 2024 marked a significant shift for Semler as they adopted a unique approach to maximizing shareholder value through a fiat to bitcoin conversion strategy. The company's chairman, Eric Semler, declared, "We firmly believe in bitcoin's long-term potential, akin to digital gold. Our commitment to increasing our bitcoin reserves signifies our confidence in this digital currency."

This shift has delivered a BTC Yield of 107%, a crucial key performance indicator that reflects the company's effective acquisition methods over this period. The strategic approach of attaining bitcoins aligns seamlessly with the firm's financial health and growth expectations, allowing them both to innovate in healthcare technology and enhance their portfolio through cryptocurrency.

Financial Metrics of 2024

When comparing results to 2023, Semler’s revenues hit $56.3 million, marking a drop of 17% from $68.2 million. Notably, the cost of revenues also declined by 32% to $4.8 million. Despite the decrease in sales, income from operations showed resilience by decreasing minimally by 6%. The reported net income for 2024 reached $40.9 million, essentially doubling from the previous year.

In the fourth quarter alone, revenues were $12.4 million, down from $15.1 million during the same period in 2023, while total operating expenses decreased sharply to $8.9 million from $12.5 million. A striking achievement was the pre-tax income, which skyrocketed to $32.6 million, nearly a tenfold increase compared to previous quarterly figures.

Future Outlook and Strategies

As they plan for 2025 and beyond, Semler Scientific is focused on bolstering its healthcare innovations while aggressively expanding its bitcoin holdings. They have engaged in an at-the-market (ATM) equity offering strategy, allowing them to raise up to $150 million from issuing their stock further fueling growth opportunities.

Moreover, the company successfully issued $100 million worth of 4.25% convertible notes in January 2025, enabling them to further their investment strategy. The positive momentum in their financial results reflects not just a sound market strategy but embodies an innovative approach toward leveraging digital assets as a core component of their growth strategy.

Conclusion

Overall, Semler Scientific has demonstrated exceptional adaptability in a rapidly changing financial landscape. Their ability to blend healthcare technology with strategic digital asset management showcases their innovative spirit. As the company positions itself for further growth, stakeholders and investors alike are optimistic about the future of Semler Scientific. The commitment to both healthcare solutions and bitcoin acquisition aligns well with ongoing trends in both markets.